SEC Filing Summary

VARKI PAUL, Chief Legal Officer of Avalo Therapeutics, Inc., acquired 24,300 shares of Common Stock on May 21, 2026. This acquisition is related to performance stock units (PSUs) granted on August 19, 2025, which vested on May 21, 2026, upon achievement of performance goals. The shares are subject to a vesting date of August 19, 2028, contingent upon continued service. Following this transaction, VARKI PAUL holds 27,934 shares of Common Stock.